Smaller companies are figuring out what to do next, and the good ones will get acquired. Here are five startups that have launched into the obesity space within the past six years and the approaches theyre pursuing
[DOI] [PMC free article] [PubMed] [Google Scholar] 35.Wald D.S., Kasturiratne A., Simmonds M
There have been safety concerns due to some compounded versions containing salt forms of the drug
It is caused by a combination of genetics and hormones
If mood changes coincide with dose increases, your healthcare provider may consider slowing the titration schedule, temporarily maintaining a lower dose, or even reducing to a 1.7mg dose to allow your body more time to adjust, as outlined in the UK SmPC
Fact: Timing matters because of digestive competition, but delivery format (liposomal vs